ʻO ka lāʻau lapaʻau maʻi

ʻO kekahi o nā loea kaulana no ka hoʻoulu ʻana i ka maʻi diabetes ka hoʻohana ʻana i ka parsley. Hāʻawi nā mea hoʻohana aku i nā koho he nui no ka lawe ʻana i ka lau bay no ka maʻi diabetes type 2. Ma hope o nā mea a pau, hiki i kēia mea kanu ke hoʻohaʻahaʻa i ke kō koko. E kū'ē i ka kiʻi o kona hāmeʻa, lele i ka pau ʻana o ka glucose.

No nā maʻi like ʻole, ua hoʻohana ʻia nā lāʻau lapaʻau e hoʻohaʻahaʻa i ke kō koko. Pono kekahi o kēia mau lāʻau e kuhikuhi e ke kauka hele mai, no ka mea, e pono e noʻonoʻo i nā hiʻohiʻona o nā maʻi kanaka. Diabetes He ʻano ʻano maʻi maʻi e ulu lōʻihi ana me nā hōʻailona latent.

ʻO ka acid lipoic Alpha, i ʻike ʻia hoʻi ma ka acioctic acid, ua hoʻokaʻawale mua ʻia mai ka bovine ate i ka makahiki 1950. Ma muli o kāna hana kemikona, ʻo ia kahi momona momona e loaʻa ana i ka lepo. Hiki ke loaʻa i loko o kēlā me kēia sela i loko o kā mākou kino, kahi e kōkua ai i ka uluʻana i ka ikehu. ʻO ka Alpha lipoic acid kahi kumu nui o ke kaʻina metabolic, ka mea e hoʻohuli i ka glucose i ka ikehu no ka pono o ke kino.

ʻO nā lāʻau lapaʻau maʻi hou e hoʻomaka nei e kū mai i nā makahiki 2000 he mau huaʻōlelo peninike. Kūmole, ua hoʻonohonoho ʻia lākou e hoʻohaʻahaʻa i ke kōhi koko ma hope o ka ʻai ʻana me ka maʻi maʻamau 2. Eia naʻe, eia nō kēia manaʻu iki lākou. No ka mea ke hana like nei kēia mau lāʻau lapaʻau e like me Siofor (metformin), a ināʻaʻole i kaʻa ka hopena, ʻoiai lākou ke uku nui nei.

Nā ʻōlelo e hoʻohana ai i ka ʻikepili hou aku i ka maʻi Diabeton MV - kahi lāʻau lapaʻau no ka maʻi diabetes type 2. ʻO ka mea waiwai e gliclazide. Hoʻokomo ia i nā hua beta pancreatic e hoʻoulu i nā insulin, e hoʻohaʻahaʻa i ke kō koko. E kuhikuhi i nā derivatives sulfonylurea. Hoʻololi nā MB i nā papa papa.

ʻO Galvus kahi lāʻau lapaʻau no ka maʻi maʻi, ka mea ikaika o ka vildagliptin, mai ka pūʻulu o DPP-4 inhibitors. Ua hoʻopaʻa inoa ʻia nā papa maʻi diabetes Galvus mai Lūkini mai 2009. Hana ʻia lākou e Novartis Pharma (Switzerland). Nā papa papa galvus no ka maʻi maʻi mai ka pūʻulu o nā DPP-4 inhibitors - ua hoʻopaʻa inoa ʻia ka waiwai ikaika Vildagliptin Galvus no ka mālama ʻana i nā maʻi maʻi me ka maʻi type 2.

Ma hope o ka hoʻopaʻa ʻana i kēia ʻatikala, e aʻo nō ʻoe e pehea e mālama ai i ka maʻi maʻamau ʻo 2 a, ma kekahi mau mea, ʻano type type like 1 me ke kōkua o nā papa. Inā kuhi ʻoe i ka maʻi maʻa, a laila ua ʻike ʻoe i kou ʻili ponoʻī ʻaʻole hiki i nā kauka ke hoʻohilahila i nā kūleʻa maoli i loko o ka mālama ʻana i ka maʻi diabetes ... koe wale nō nā mea i hoʻopilikia ʻole e aʻo i kā mākou pūnaewele.

ʻO Siofor ka lāʻau kaulana loa i ka honua no ka pale a me ka mālama ʻana i ka maʻi type 2. Siofor ka inoa kālepa no ka lāʻau lapaʻau e hoʻohana ai i nā metformin ikaika. Māhuahua kēia lāʻau lapaʻau i ka naʻau o nā cell i ka hana o ka insulin, i.e., hōʻemi i ka pale ʻana i ka insulin. ʻO nā papa ʻo Siofor a me Glucofage e pono ai ʻoe e ʻike: Siofor no ka maʻi type 2.